Category - New Drugs
FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections
FDA Approves Brukinsa (zanubrutinib) for the Treatment of Mantle Cell Lymphoma
FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions
FDA Approves Ziextenzo (pegfilgrastim-bmez), a Biosimilar to Neulasta
FDA Approves Talicia (omeprazole magnesium, amoxicillin and rifabutin) for the Treatment of H. pylori Infection in Adults
FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older
FDA Approves Vumerity (diroximel fumarate) for Multiple Sclerosis
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years